// App-Quantinova.ai

284 ⋆ : Elevated Hepatic Biochemistry Predicts Recurrent Primary Sclerosing Cholangitis in the First 12 Months Following Liver Transplantation

Researchers

Presenter

  • Wasilenko T. Shawn

Principal Investigators

  • Ellina Lytvyak

  • Emmanuel Tsochatzis

  • Reena Ravikumar

  • Sophie Jose

  • Michael E. Allison

  • Bridget Gunson

  • Derek Manas

  • Andrea Monaco

  • Darius Mirza

  • Giuseppe Fusai

  • Nicola E. Owen

  • Douglas Thorburn

  • Keith J. Roberts

  • Parthi Srinivasan

  • Stephen J. Wigmore

  • Andrew K. Burroughs

  • Anuja Athale

  • Felicity Creamer

  • Bimbi Fernando

  • Vikram Iyer

  • Mansoor Madanur

  • Gourab Sen

  • Andrew Mason

Medical Centers

  • UCL, Institute of Liver and Digestive Health, London, United Kingdom

  • University of Alberta, Edmonton, AB, Canada

Locations

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Primary sclerosing cholangitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved